SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
ART: InSTIs AND TOXICITY
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
THEMED DISCUSSION LEADER
Alan Winston
Imperial College London, London, United Kingdom
NEUROPSYCHIATRIC OUTCOMES BEFORE AND AFTER SWITCHING TO DOLUTEGRAVIR-BASED THERAPY (ABSTRACT
440)
Phillip Chan
SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
NEUROPSYCHOLOGICAL CHANGES IN EFAVIRENZ SWITCH REGIMENS IN MACS (ABSTRACT
441)
Yijia Li
University of Pittsburgh, Pittsburgh, PA, USA
MEMORY AND LEARNING DYSFUNCTION WITH INTEGRASE STRAND TRANSFER INHIBITORS USE (ABSTRACT
442)
Jane A O'Halloran
Washington University in St Louis, St Louis, MO, USA
CEREBRAL FUNCTION PARAMETERS IN PEOPLE LIVING WITH HIV SWITCHING INTEGRASE INHIBITOR (ABSTRACT
443)
Borja Mora-Peris
Imperial College London, London, United Kingdom
CENTRAL NERVOUS SYSTEM EFFECTS OF THERAPY INITIATION WITH INTEGRASE INHIBITORS (ABSTRACT
439)
Jose A. Muñoz-Moreno
Lluita contra la SIDA Foundation - Germans Trias i Pujol University Hospital, Badalona, Barcelona, Catalonia, Spain
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
